<p>Fortress Biotech Inc. has announced the issuance of warrants in connection with a private placement, as disclosed in a recent Form 8-K filing. The warrants are being issued in a transaction exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Further details regarding the terms of the warrants will be provided in subsequent company filings. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fortress Biotech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-121187), on December 15, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

FBIO

<p>Fortress Biotech Inc. announced the issuance of warrants in a private placement, exempt from registration under Section 4(a)(2) of the Securities Act of 1933. Details will be provided in future filings. This information was disclosed in a Form 8-K filing.</p>

Fortress Biotech Announces Unregistered Sale of Warrants in Private Placement